eMedicine Specialties > Ophthalmology > Hematologic & Cardiovascular Disorders
Ocular Ischemic Syndrome
Updated: May 13, 2009
Introduction
Background
Ocular ischemic syndrome (OIS) encompasses the ocular signs and symptoms that result from chronic vascular insufficiency. Common anterior segment findings include advanced cataract, anterior segment inflammation, and iris neovascularization. Posterior segment signs include narrowed retinal arteries, dilated but nontortuous retinal veins, midperipheral dot-and-blot retinal hemorrhages, cotton-wool spots, and optic nerve/retinal neovascularization. The presenting symptoms include ocular pain and abrupt or gradual visual loss.1,2,3,4,5,6,7
Pathophysiology
The most common etiology of OIS is severe unilateral or bilateral atherosclerotic disease of the internal carotid artery or marked stenosis at the bifurcation of the common carotid artery. OIS may also be caused by giant cell arteritis. It is postulated that the decreased vascular perfusion results in tissue hypoxia and increased ocular ischemia, leading to neovascularization.3,8,9
Frequency
United States
The true incidence of OIS is unknown. It is estimated that approximately 5% of patients with marked carotid artery stenosis present with OIS. By extrapolating data from previous studies, and by applying it to the population of the United States, approximately 1800 new cases (7.5 cases per 1 million population) are encountered per year.
Mortality/Morbidity
The 5-year mortality rate in patients with OIS is about 40%. The leading cause of death is cardiac disease, followed by stroke and cancer. Predisposing risk factors for atherosclerosis (eg, hypertension, diabetes mellitus) have a higher prevalence in patients with OIS than in age-matched populations.
Sex
Males are affected more frequently than females, by a ratio of approximately 2:1.
Age
OIS mainly affects elderly patients. The age range is 50-80 years, with a mean age range of 65-68 years. OIS is uncommon in patients younger than 50 years.
Clinical
History
Symptoms can include amaurosis fugax, gradual or sudden visual loss, and pain. The diagnosis of OIS should always be suspected in elderly patients with asymmetric anterior uveitis, hypotony, neovascularization cataract, and retinopathy.1,10
- Loss of vision
- Loss of visual acuity is the most frequently encountered symptom, present in 70-90% of patients at the time of presentation. Only a minority of patients (<10%) have no visual complaints.
- Patients with OIS can present with variable degrees of visual loss. Up to two thirds of patients can present with visual acuities of 20/60 or worse. One third of patients will have visual acuities of counting fingers or worse. Although, in most cases, visual loss occurs gradually over a period of weeks to months, in some cases, it can also occur abruptly.
- Pain: About 40% of patients with OIS will present with symptoms of pain. The pain is characteristically described as a dull ache over the brow, which begins gradually over a period of hours to days.
- Amaurosis fugax: Amaurosis fugax is a transient episode of complete or partial monocular blindness, lasting for a period of less than 10 minutes. A history of amaurosis fugax is elicited in 9-15% of patients with OIS.
Physical
- Cardiovascular examination
- Arm pulses
- Cardiac auscultation
- Carotid auscultation
- Ophthalmic examination
- Anterior segment1,3
- Corneal abnormalities: Descemet folds and corneal edema may be present secondary to ocular hypotony or increased intraocular pressure.
- Iris neovascularization: Iris neovascularization is encountered in 67-87% of affected eyes.
- Neovascular glaucoma: This is elevated intraocular pressure in the presence of angle neovascularization. Neovascular glaucoma is seen in about one third of patients with OIS. Lower arterial perfusion to the ciliary body may induce hypotony or normal intraocular pressure despite significant anterior chamber angle neovascularization.
- Anterior chamber inflammation: Uveitis, characterized by the presence of cells and flare in the anterior chamber, was estimated to occur in up to 20% of eyes. In most cases, the inflammatory reaction is only mild.
- Cataract: Advanced degrees of lens opacities may be seen in patients with OIS.
- Posterior segment1,3,11
- Retinal vessels: Retinal arteries are typically narrow in eyes with OIS. The veins are usually irregularly dilated but not tortuous.
- Retinal hemorrhages: Midperipheral dot-and-blot retinal hemorrhages are observed in 24-80% of eyes with OIS. Microaneurysms can also be seen.
- Cotton-wool spots: These are seen in approximately 5% of eyes with OIS and are typically located in the posterior pole.
- Neovascularization: Neovascularization of the optic nerve is seen in 13-35% of eyes with OIS. Retinal neovascularization is less common, and occurs in 3-8% of cases. Neovascularization of the optic nerve can be mild, or it can progress into extensive fibrous proliferation, causing secondary vitreous hemorrhage and tractional retinal detachment.
- Cherry-red spot: The cherry-red spot appears as a result of ischemia involving the inner layers of the retina, as typically seen in cases of central retinal artery occlusion. It is noted in 12% of eyes with OIS.
- Optic disc: Optic disc pallor, cupping, or edema is also noted in patients with OIS.
- Orbit: Ocular ischemia can be part of a rare orbital compartment syndrome that occurs after prolonged spinal surgery in the prone position and was first described by Hollenhorst more than 50 years ago.12,13 These patients can present with significant proptosis, ophthalmoplegia, eyelid swelling, and ocular ischemia. The exact mechanism is not known, but it is hypothesized that the tamponade action from pressure of the ocular content causes partial or complete collapse of the orbital arterial and venous channels. When the external pressure is released, the ischemic vessels dilate and fluid transudates into the tissue spaces, causing orbital edema.
- Anterior segment1,3
Causes
- High-grade carotid stenosis: Stenosis of the carotid artery results in concomitant chronic ophthalmic artery insufficiency. Abnormalities of both anterior and posterior segments of the globe are a result of reduced oxygen delivery to the eye.
- Vascular occlusive disease includes occlusive disease of the aortic arch, ophthalmic artery, central retinal artery, and ciliary arteries.
More on Ocular Ischemic Syndrome |
Overview: Ocular Ischemic Syndrome |
| Differential Diagnoses & Workup: Ocular Ischemic Syndrome |
| Treatment & Medication: Ocular Ischemic Syndrome |
| Follow-up: Ocular Ischemic Syndrome |
| References |
| Next Page » |
References
Brown GC, Magargal LE. The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol. Feb 1988;11(4):239-51. [Medline].
Brown GC. Ocular ischemic syndrome. In: Retina. 2nd ed. Mosby;1994: 1515-27.
Kahn M, Green WR, Knox DL, et al. Ocular features of carotid occlusive disease. Retina. Winter 1986;6(4):239-52. [Medline].
Kearns TP, Hollenhurst RW. Venous-stasis retinopathy of occlusive disease of the carotid artery. Proc Staff Meet Mayo Clin. Jul 17 1963;38:304-12. [Medline].
Eugene JR, Abdallah M, Miglietta M, et al. Carotid occlusive disease: primary care of patients with or without symptoms. Geriatrics. May 1999;54(5):24-6, 29-30, 33 passim. [Medline].
Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome. Ophthalmology. May 1997;104(5):859-64. [Medline].
Chen CS, Miller NR. Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management. Compr Ophthalmol Update. Jan-Feb 2007;8(1):17-28. [Medline].
Smith VH. Pressure changes in the ophthalmic artery after carotid occlusion (an experimental study in the rabbit). Br J Ophthalmol. 1961;45:1-26.
Takaki Y, Nagata M, Shinoda K, et al. Severe acute ocular ischemia associated with spontaneous internal carotid artery dissection. Int Ophthalmol. Dec 2008;28(6):447-9. [Medline].
Kubicka-Trzaska A, Romanowska-Dixon B. Non-malignant uveitis masquerade syndromes. Klin Oczna. 2008;110(4-6):203-6. [Medline].
Ho TY, Lin PK, Huang CH. White-centered retinal hemorrhage in ocular ischemic syndrome resolved after carotid artery stenting. J Chin Med Assoc. May 2008;71(5):270-2. [Medline].
Hollenhorst RW, Svien HJ, Benoit CF. Unilateral blindness occurring during anaesthesia for neuro- surgical operations. Arch Ophthalmol. 1954;52:819-30.
Leibovitch I, Casson R, Laforest C, et al. Ischemic orbital compartment syndrome as a complication of spinal surgery in the prone position. Ophthalmology. Jan 2006;113(1):105-8. [Medline].
Casson RJ, Fleming FK, Shaikh A, et al. Bilateral ocular ischemic syndrome secondary to giant cell arteritis. Arch Ophthalmol. Feb 2001;119(2):306-7. [Medline].
Hwang JM, Girkin CA, Perry JD, et al. Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment. Am J Ophthalmol. Jan 1999;127(1):102-4. [Medline].
Bosley TM. The role of carotid noninvasive tests in stroke prevention. Semin Neurol. Jun 1986;6(2):194-203. [Medline].
Ho AC, Lieb WE, Flaharty PM, et al. Color Doppler imaging of the ocular ischemic syndrome. Ophthalmology. Sep 1992;99(9):1453-62. [Medline].
Lee HM, Fu ER. Orbital colour Doppler imaging in chronic ocular ischaemic syndrome. Aust N Z J Ophthalmol. 1997;25:157-63. [Medline].
Sivalingam A, Brown GC, Magargal LE. The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment. Int Ophthalmol. Jan 1991;15(1):15-20. [Medline].
Amselem L, Montero J, Diaz-Llopis M, et al. Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome. Am J Ophthalmol. Jul 2007;144(1):122-4. [Medline].
Klais CM, Spaide RF. Intravitreal triamcinolone acetonide injection in ocular ischemic syndrome. Retina. 2004;24:459-61. [Medline].
Wolintz RJ. Carotid endarterectomy for ophthalmic manifestations: Is it ever indicated?. J Neuroophthalmol. 2005;25:299-302. [Medline].
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. Aug 15 1991;325(7):445-53. [Medline].
Ros MA, Magargal LE, Hedges TR Jr, et al. Ocular ischemic syndrome: long-term ocular complications. Ann Ophthalmol. Jul 1987;19(7):270-2. [Medline].
Sivalingam A, Brown GC, Magargal LE, et al. The ocular ischemic syndrome. II. Mortality and systemic morbidity. Int Ophthalmol. May 1989;13(3):187-91. [Medline].
Further Reading
Keywords
ocular ischemic syndrome, OIS, venous stasis retinopathy, ischemic ocular inflammation, ischemic oculopathy, carotid occlusive disease
Overview: Ocular Ischemic Syndrome